SCA Injectable Medications Recalled for Lack of Sterility Assurance

Summary

SCA Pharmaceuticals, LLC has recalled 112,812 units of various injectable medications, including fentanyl, hydromorphone, and phenylephrine, because they lack assurance of sterility. Using these products could potentially lead to serious or life-threatening infections, as the lack of sterility assurance means the medications may be contaminated with microorganisms. No injuries or adverse events have been reported to date, and the products were distributed nationwide to healthcare facilities and hospitals.

Risk

A lack of sterility assurance in injectable medications poses a significant health risk because the product is administered directly into the bloodstream or body tissues. If contaminated, the medication can cause severe infections that are especially dangerous for patients who are already ill or have weakened immune systems.

Additional Information